Top Page
Q & M Dental Group (Singapore) Limited
(SGX:QC7)
Q & M Dental Group (Singapore) Limited (QC7) vs. S&P 500 (SPY)
Q & M Dental Group (Singapore) Limited Business Overview & Revenue Model
Q & M Dental Group (Singapore) Limited Financial Statement Overview
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 180.67M | 182.72M | 181.21M | 205.60M | 137.62M | Gross Profit |
| 54.36M | 50.52M | 156.04M | 174.72M | 120.72M | EBIT |
| 54.36M | 49.95M | 23.39M | 45.94M | 26.41M | EBITDA |
| 29.30M | 37.18M | 35.78M | 63.72M | 37.80M | Net Income Common Stockholders |
| 14.64M | 11.52M | 11.31M | 30.47M | 19.70M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 34.34M | 33.99M | 39.70M | 47.61M | 48.77M | Total Assets |
| 247.77M | 258.59M | 267.41M | 276.18M | 273.78M | Total Debt |
| 115.38M | 130.27M | 140.82M | 137.93M | 126.81M | Net Debt |
| 81.04M | 96.28M | 101.12M | 90.32M | 78.04M | Total Liabilities |
| 139.27M | 155.68M | 165.16M | 172.94M | 149.85M | Stockholders Equity |
| 106.17M | 99.07M | 96.49M | 97.85M | 121.08M |
| Cash Flow | Free Cash Flow | |||
| 32.15M | 26.71M | 22.58M | 41.93M | 16.49M | Operating Cash Flow |
| 40.10M | 33.26M | 33.55M | 50.79M | 23.75M | Investing Cash Flow |
| -6.31M | -6.96M | -10.99M | 3.55M | 41.75M | Financing Cash Flow |
| -33.44M | -32.01M | -30.47M | -55.51M | -43.98M |
Q & M Dental Group (Singapore) Limited Peers Comparison
Q & M Dental Group (Singapore) Limited Corporate Events
Q & M Dental Group (Singapore) Limited announced that its associated company, EM2AI Pte. Ltd., has received a Medical Devices Included Class 1 licence from the Australian Government, allowing it to sell and distribute dental AI solutions in Australia. This development enables EM2AI to integrate its AI solutions into a customer’s platform in Australia, expanding its user network, and the company is actively seeking to broaden its reach in various Southeast Asian markets.
Q & M Dental Group’s associated company, EM2AI Pte. Ltd., has entered into a definitive agreement with a regional dental solutions provider to integrate its AI solutions into the provider’s platform. This collaboration marks a significant milestone for EM2AI, allowing it to extend its services to over 1,100 clinics across Singapore, Malaysia, Thailand, and Vietnam, thereby enhancing its market footprint and potentially increasing shareholder value.
Q & M Dental Group has reached a settlement agreement with Dr Ong, following her termination as CEO of Acumen. The settlement, which is confidential, resolves all disputes without any admission of liability, and no further investigations will be pursued regarding Dr Ong’s involvement with Acumen’s supplier assets.
Q & M Dental Group’s subsidiary, Q & M College of Dentistry, has achieved the EduTrust Provisional certification from SkillsFuture Singapore, marking a significant milestone in its commitment to high-quality education. This certification allows the college to enroll international students, enhancing its educational offerings and potentially expanding its market reach.
Q & M Dental Group (Singapore) Limited announced that the High Court of Malaya at Kuala Lumpur has recognized the arbitral award in favor of its subsidiary in Malaysia, QDGM, as binding. The defendants’ application to set aside this enforcement order was dismissed, although they have appealed the decision. This development supports Q & M’s position in the ongoing legal proceedings and could have implications for its financial standing and stakeholder interests.
Q & M Dental Group’s associated company, EM2AI Pte. Ltd., has entered into a memorandum of understanding with a prominent dental solutions provider in the region, marking a significant step in its business expansion. This partnership will allow EM2AI to integrate its dental AI solutions across a network of approximately 1,000 clinics in Singapore, Malaysia, Thailand, and Vietnam, potentially increasing its user base to over 1,100 clinics, which is expected to contribute positively to shareholder value.
Q & M Dental Group (Singapore) Limited announced that its associated company, EM2AI Pte. Ltd., has received medical device licenses in Thailand, Philippines, Vietnam, and Indonesia for its dental AI solutions. This development enables EM2AI to expand its sales and distribution network across these new markets, actively seeking distributors and customers, thereby enhancing its business growth and the company’s regional market positioning.